BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34581725)

  • 1. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
    Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity.
    Tsang A; Kanda P; Gottlieb C; Virgili G; Kantungane L; Coupland S
    Doc Ophthalmol; 2022 Apr; 144(2):117-124. PubMed ID: 34762206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
    Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
    Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.
    Ruberto G; Bruttini C; Tinelli C; Cavagna L; Bianchi A; Milano G
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2201-2210. PubMed ID: 30151601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity.
    Debellemanière G; Flores M; Tumahai P; Meillat M; Bidaut Garnier M; Delbosc B; Saleh M
    Acta Ophthalmol; 2015 Nov; 93(7):e534-40. PubMed ID: 25989823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
    Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
    Bulut M; Akıdan M; Gözkaya O; Erol MK; Cengiz A; Çay HF
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
    Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
    Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible early sign of hydroxychloroquine macular toxicity.
    Brandao LM; Palmowski-Wolfe AM
    Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.
    Allahdina AM; Stetson PF; Vitale S; Wong WT; Chew EY; Ferris FL; Sieving PA; Cukras C
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1953-1963. PubMed ID: 29677357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
    Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
    Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
    Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
    Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.